Cytochrome P450-Mediated Metabolism of Haloperidol and Reduced Haloperidol to Pyridinium Metabolites-Reference-Cited by-同舟云学术

Cytochrome P450-Mediated Metabolism of Haloperidol and Reduced Haloperidol to Pyridinium Metabolites

Published:2006-06-13 Issue:7 Volume:19 Page:914-920
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Avent Kathryn M.¹,DeVoss J. J.¹,Gillam Elizabeth M. J.¹

Affiliation:

1. School of Biomedical Sciences, and School of Molecular and Microbial Sciences, The University of Queensland, and Queensland Centre for Schizophrenia Research, Saint Lucia, Brisbane, Queensland, Australia 4072

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/tx0600090

Reference37 articles.

1. Determination of the pyridinium metabolite derived from haloperidol in brain tissue, plasma and urine by high-performance liquid chromatography with fluorescence detection

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes;Archives of Toxicology;2024-03-23

2. The Role of Drug Metabolism in Toxicity;Drug Metabolism Handbook;2022-11-18

3. Pharmacokinetic drug interactions with oral haloperidol in adults: dose correction factors from a combined weighted analysis;Expert Opinion on Drug Metabolism & Toxicology;2022-02-01

4. Human Family 1–4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update;Archives of Toxicology;2021-01-18

5. Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance;RSC Medicinal Chemistry;2021